Brief: Enliven Therapeutics Entered Into Open Market Sale Agreement With Jefferies Relating To Sale Of Up To $200 Mln Common Stock
06/07/2023 22:41
July 6 (Reuters) - Enliven Therapeutics Inc ELVN.O :
* ENLIVEN THERAPEUTICS INC - HAVE ENTERED INTO AN OPEN
MARKET SALE
AGREEMENT WITH JEFFERIES RELATING TO SALE OF UP TO $200 MILLION
COMMON STOCK- SEC FILING
Further company coverage: ELVN.O
Recent news on Enliven Therapeutics
See all newsBrief: Enliven Therapeutics Appoints Kristine Ball To Board Of Directors Ahead Of Planned Phase 3 Trial Initiation This Year
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Enliven Therapeutics Q2 net loss widens on higher expenses